Covered recipient · General Payments record
AUDREY RACHELLE PUENTES
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2024
$425.04
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.04 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $154.94 | 7 |
| SHIELD THERAPEUTICS INC | $107.60 | 2 |
| Astellas Pharma US Inc | $35.30 | 2 |
| Organon LLC | $32.93 | 2 |
| Exeltis, USA Inc. | $30.23 | 2 |
| CONMED Corporation | $25.46 | 1 |
| PFIZER INC. | $21.88 | 1 |
| Avanos Medical | $16.70 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $425.04 | 18 |
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $17.19 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139390926 | CMS |
| Astellas Pharma US Inc | $18.11 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139422711 | CMS |
| Avanos Medical | $16.70 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149308227 | CMS |
| Biogen, Inc. | $22.84 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104864186 | CMS |
| Biogen, Inc. | $19.44 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104852626 | CMS |
| Biogen, Inc. | $23.83 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104874392 | CMS |
| Biogen, Inc. | $24.21 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104838242 | CMS |
| Biogen, Inc. | $22.41 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104863022 | CMS |
| Biogen, Inc. | $21.91 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104820396 | CMS |
| Biogen, Inc. | $20.30 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104858300 | CMS |
| CONMED Corporation | $25.46 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142400552 | CMS |
| Exeltis, USA Inc. | $17.05 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150002498 | CMS |
| Exeltis, USA Inc. | $13.18 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150002500 | CMS |
| Organon Llc | $19.65 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136226506 | CMS |
| Organon Llc | $13.28 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136226510 | CMS |
| PFIZER INC. | $21.88 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131666894 | CMS |
| SHIELD THERAPEUTICS INC | $22.20 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150144148 | CMS |
| SHIELD THERAPEUTICS INC | $85.40 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150158068 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.